Data Bridge Market Research analyses that the NGS-based RNA-sequencing market which was USD 2.44 billion in 2021, would rocket up to USD 10.42 billion by 2029, and is expected to undergo a CAGR of 19.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get a PDF Sample of NGS-Based RNA-Sequencing Market – https://www.databridgemarketresearch.com/request-a-sample/?dbmr=Glo...

NGS-based RNA-seq is widely employed for sophisticated and comprehensive genomic insights in both standard and non-traditional applications. The growing demand for better sequencing-based diagnostics has fueled the development of novel sequencing technologies. As a result, demand for technologies like high-throughput sequencers and portable units has skyrocketed. The market for NGS-based RNA-seq is increasing due to a number of causes, including technological developments in RNA-seq products, the advantages of RNA-seq over microarray technology, rapid expansion in research activities, an increase in RNA-seq awards, and a high need for precision medicine.

Market Definition

The term “next-generation sequencing,” sometimes known as “high-throughput sequencing,” refers to a variety of current sequencing technologies. In the future years, the market is likely to rise due to an increased focus on genetic studies and gene-based medicinal technologies.

NGS-Based RNA-Sequencing Market Dynamics

Drivers

Increasing R&D activities

Increased research activity, rising demand for precision medicine, and growing benefits of RNA-Seq In the projected period of 2022-2029, the increasing number of RNA-Seq grants is expected to boost the growth of the NGS-based RNA-sequencing market. Increasing levels of investment in cancer research as well as the agriculture sector, on the other hand, will propel the NGS-based RNA-sequencing market forward over the projection period.

Demand of NGS sequencing

The demand for next-generation sequencing technology increased dramatically after its launch. It is widely utilised in both traditional and non-traditional applications to obtain advanced and comprehensive genetic insights. The growing demand for enhanced sequencing-based diagnostics has fueled the development of brand-new sequencing technologies. As a result, equipment like robust high-throughput sequencers and portable units have exploded in popularity.

Technological advancements in sequencing platforms

Continuous advancements in sequencing technology have allowed for the development of efficient, portable, and easy-to-use NGS sequencers that give speedy and exact results while minimising turnaround times. As a result, leading companies are continually focused on investing in research activities for new product development to improve their positions in this high-growth industry.

Opportunities

In recent years, advances in next-generation sequencing, like paired-end (PE) sequencing, have enabled library preparation to produce twice as many reads simultaneously. Sequencing both ends of DNA fragments in the library and aligning forward and reverse reads as reading pairs are used in this procedure. Sequences with more accurate read alignment and, hence, the ability to detect indels, which is not achievable with single-read data, have also been enabled by the approaches. The paired-end strategy is the most modern and well-liked technique among the researchers.

Restraints/Challenges

In the forecast period, the lack of qualified specialists, lack of diagnostic testing standards, and instability of RNA under normal settings are anticipated to hamper the expansion of the NGS-based RNA-sequencing market. Furthermore, the rise of service provider companies that have joined the market and are offering next-generation sequencing at a lower cost.

This NGS-based RNA-sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the NGS-based RNA-sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

To Gain More Insights into the Market Analysis, Browse Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-ngs-based-r...

Recent Development

In May 2021, SEQuoia RiboDepletion Kit for NGS, developed by Bio-Rad Laboratories, Inc., removes unnecessary ribosomal RNA from the RNA-sequencing library and enhances test efficiency.

In March 2022, Element Biosciences Inc. has released the Element AVITI System, a benchtop sequencer that provides an unmatched mix of performance, affordability, and flexibility. A benchtop NGS instrument and related consumables make up this system.

Global NGS-Based RNA-Sequencing Market Scope

The NGS-based RNA-sequencing market is segmented on the basis of type, skin site and diseases. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Service

Sample Preparation Products

Sequencing Platforms and Consumables

Sequencing Services

Data Analysis, Storage, and Management

Technology

Sequencing by Synthesis

Ion Semiconductor Sequencing

Single-molecule Real-time Sequencing

Nanopore Sequencing

Application

Expression Profiling Analysis

Small RNA Sequencing

De Novo Transcriptome Assembly

Variant Calling and Transcriptome Epigenetics

End User

Research and Academia

Hospitals and Clinics

Pharmaceutical and Biotechnology Companies

Other End Users

Browse the complete table of contents at – https://www.databridgemarketresearch.com/toc/?dbmr=Global-NGS-Based...

Some of the major players operating in the NGS-based RNA-sequencing market are:

Illumina Inc. (US)

Thermo Fischer Scientific Inc. (US)

Oxford Nanopore Technologies plc (UK)

Agilent Technologies, Inc. (US)

BGI (China)

PerkinElmer Inc. (US)

QIAGEN (Germany)

Eurofins Scientific (Luxembourg)

F. Hoffmann-La Roche Ltd (Switzerland)

Takara Bio Inc. (Japan)

GENEWIZ, Inc. (US)

Hamilton Company (US)

Macrogen Inc. (South Korea)

Zymo Research Corporation (US)

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- [email protected]